earnings call
The company increased its overall year-over-year revenue by 5% in Q2.
Also: uBiome's FBI investigation; Better Therapeutics' pivotal trial plans.
The company anticipates some earnings losses and a gross margin contraction in the earlier part of 2019, but hopes its health business will exceed $100 million before the end of the year.
The CGM giant also redrafted its agreement with Verily, whose tech will now be incorporated into their core product line.
UnitedHealth Group finished Q3 2018 with 12 percent year-over-year revenue growth.
In its Q3 2018 earnings call, the company said that diversifying its business model has help stem losses from the declining fitness tracker market.
Shortly after launching its integrated continuous glucose monitoring system, Dexcom announced a 42 percent increase in year-over-year sales during its Q2 earnings call.
The second quarter of 2018 was a strong one for the rapidly expanding DarioHealth.
Not two months after getting the FDA nod for its implantable CGM, Eversense, Senseonics held its Q2 earnings call reporting a increase in year over year revenues.
It was a bit of a bumpy start, but it’s beginning to look like Fitbit’s push into the smartwatch market is bearing fruit.